Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rice Krispies immunity claims under fire

This article was originally published in The Tan Sheet

Executive Summary

The Kellogg Co. and the Oregon Department of Justice settle a case involving the marketer's claims that Rice Krispies cereal "helps support your child's immunity," the Oregon Attorney General John Kroger's office reports. The settlement requires Kellogg to stop shipping cereal boxes with the immunity language by Jan. 15, destroy more than 2 million units of packaging with the claim and cease making such claims unless it provides the Oregon Department of Justice with "advance notice and competent reliable scientific evidence." Additionally, the company agrees to donate nearly 500,000 boxes of cereal to organizations that feed the hungry. Kellogg made the immunity claim as part of a campaign for Rice Krispies, Cocoa Krispies, Frosted Krispies and MultiGrain Jumbo Krispies. FDA warned cereal maker General Mills over heart health claims made for Cheerios oat cereal in 2009 (1"The Tan Sheet" May 18, 2009)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103689

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel